ClinicalTrials.gg
CompletedNCT06615518Updated Jun 10, 2026

Comparison of Clinical Effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in Patients With Lumbar Disc Herniation

An interventional study of FELD (Full-Endoscopic Lumbar Discectomy), comprising IELD and TELD as anatomical subgroups and Microdiscectomy in Lumbar Degenerative Disease, Lumbar Radiculopathy and Sciatic Leg Pain, sponsored by University of Opole. Completed at 2 sites in Poland. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by University of Opole · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Mar 2024, registered Sep 2024).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The goal of this clinical trial is to compare the clinical effectiveness of Full Endoscopic Lumbar Discectomy (FELD) and Microdiscectomy (MD) in patients aged 18-85 with single-level lumbar disc herniation who have not undergone prior lumbar surgery. This study also aims to perform a radiological analysis of MRI scans before and after treatment to optimize patient selection and surgical strategies. The main questions it aims to answer are:

  • Does FELD provide superior early postoperative pain relief (measured by VAS) compared to MD?
  • Does FELD offer better functional recovery (measured by COMI and ODI scores) postoperatively compared to MD?
  • Can radiological analysis of pre- and post-operative MRI images help optimize patient qualification and guide surgical strategies?

Researchers will compare patients undergoing FELD to those undergoing MD to see if endoscopic techniques result in faster recovery and lower early postoperative pain while maintaining similar long-term outcomes. The study will also analyze how MRI findings correlate with clinical outcomes to refine operative decision-making.

Participants will:

  • Undergo either FELD or MD surgery
  • Complete VAS, COMI, and ODI questionnaires at pre-specified follow-up intervals (1, 3, 6, and 12 months post-surgery)
  • Have MRI scans 24 hours before surgery, 24 hours after surgery, and at each follow-up to assess disc recurrence, residual pathology, and to optimize surgical strategies.
02

Conditions studied

  • Lumbar Degenerative Disease
  • Lumbar Radiculopathy
  • Sciatic Leg Pain
  • Sciatic Nerve Compression
  • Discopathy
  • Disc Herniation
  • Disc Herniation With Radiculopathy
03

In context

Radiculopathy

483 studies on the registry are indexed under Radiculopathy; 144 are open to participants now.

This study's enrollment of 200 is above the median of 60 across 373 interventional studies indexed under Radiculopathy.

Browse Radiculopathy studies →

Lead sponsor

University of Opole is the lead sponsor of 2 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-85 years with symptoms of sciatica lasting more than 6 weeks
  • Shorter duration in cases where symptoms significantly impair normal functioning or in cases of muscle strength deficits
  • Symptoms correlate with MRI findings of lumbar spine pathology, showing the presence of intervertebral disc herniation (protrusion, extrusion, or sequestration) causing nerve root compression in the lumbar spine.

Exclusion criteria

Exclusion Criteria:

  • Previous lumbar spine surgery in the lumbar-sacral region
  • MRI findings showing degenerative or stenotic spinal canal changes
  • Multi-level pathology where identification of the pain source is not possible
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    FELD

    FELD (Full-Endoscopic Lumbar Discectomy), comprising IELD and TELD as anatomical subgroups

    Procedure: FELD (Full-Endoscopic Lumbar Discectomy), comprising IELD and TELD as anatomical subgroups

  • Active comparator
    MD

    microdiscectomy

    Procedure: Microdiscectomy

Interventions

  • ProcedureFELD (Full-Endoscopic Lumbar Discectomy), comprising IELD and TELD as anatomical subgroups

    FELD is a minimally invasive spine surgery technique performed through small incisions using an endoscope. The procedure involves accessing the herniated disc through either the transforaminal (TELD) or interlaminar (IELD) approach, depending on the location of the disc herniation. The endoscopic approach allows for direct visualization of the affected area using a camera, and specialized instruments are used to remove the herniated portion of the disc. What distinguishes this intervention: * Small incisions (5-7mm) result in less soft tissue damage compared to traditional open surgery. * Real-time endoscopic visualization allows for precise disc removal and reduced trauma to surrounding structures such as muscles and ligaments. * Minimized postoperative pain and faster recovery times due to the less invasive nature of the procedure. * Outpatient or short hospital stay is often possible, contributing to faster patient discharge.

  • ProcedureMicrodiscectomy

    Microdiscectomy is a conventional surgical technique for treating lumbar disc herniation, involving a small open incision. In this procedure, the surgeon makes an incision typically between 2-3 cm in length, then uses an operating microscope to gain magnified visualization of the herniated disc. The surgeon removes part of the lamina (laminotomy) to access the disc and nerves. Special instruments are used to remove the herniated portion of the disc that is compressing the spinal nerves, relieving symptoms such as pain, numbness, and weakness. What distinguishes this intervention: * Larger incision (2-3 cm) compared to FELD, but still smaller than traditional open discectomy, allowing better visualization. * Microscopic magnification allows precise removal of disc material while minimizing trauma to surrounding neural structures. * Direct access to the affected area via the removal of part of the lamina (laminotomy), offering a well-established and highly effective approach to reli

06

What researchers measure

Primary outcomes

  1. Change in Back and Leg Pain Intensity (measured by the Visual Analog Scale [VAS])

    Description: The primary outcome measure will assess changes in back and leg pain intensity reported by patients using the Visual Analog Scale (VAS) at each follow-up. The reduction in pain scores will be compared between the FELD and MD groups to evaluate which technique provides superior pain relief over time.

    Time frame: Baseline, 1 month, 3 months, 6 months, 12 months post-surgery

Secondary outcomes

  1. Change in Functional Disability (measured by the Oswestry Disability Index [ODI])

    This measure will assess the improvement in functional disability using the ODI, comparing the degree of disability reduction between the FELD and MD groups at each follow-up point.

    Time frame: Baseline, 1 month, 3 months, 6 months, 12 months post-surgery

  2. Change in Overall Patient Well-Being (measured by the Core Outcome Measures Index [COMI])

    The COMI questionnaire will be used to evaluate changes in the patient's overall perception of their condition, including pain, function, and quality of life. Comparisons will be made between FELD and MD groups to assess which method leads to a greater improvement in patient well-being.

    Time frame: Baseline, 1 month, 3 months, 6 months, 12 months post-surgery

  3. Recurrence Rate of Disc Herniation (measured by MRI and clinical assessment)

    The rate of recurrent disc herniation will be monitored through MRI scans and clinical evaluations. The rate of recurrence in both the FELD and MD groups will be compared to determine if one technique results in a higher recurrence rate.

    Time frame: 1 month, 3 months, 6 months, 12 months post-surgery

  4. Time to Return to Work

    This measure will assess the number of days taken for patients to return to their regular work activities post-surgery, comparing the recovery times between the FELD and MD groups.

    Time frame: Up to 12 months post-surgery

07

Study locations

2 sites
  • Uniwesytecki Szpital Kliniczny
    Opole, Opole Voivodeship 45-001, Poland
  • Wojewódzki Szpital Specjalistyczny im Św Jadwigi w Opolu
    Opole, Opole Voivodeship 45-221, Poland
08

References and documents

Individual participant data

Plan to share: Yes — The following specific Individual Participant Data (IPD) will be shared: De-identified individual clinical data: This includes data from questionnaires such as Visual Analog Scale (VAS), Core Outcome Measures Index (COMI), and Oswestry Disability Index (ODI), collected at baseline and during follow-up visits (1, 3, 6, and 12 months post-surgery). De-identified radiological data: MRI images taken 24 hours before surgery, 24 hours after surgery, and at each follow-up visit will be shared for the purpose of comparing radiological outcomes. De-identified recurrence and complication data: This includes any clinical or radiological evidence of recurrent disc herniation or complications (e.g., infection, reoperation). The data will be made available upon reasonable request for research purposes to qualified researchers following the publication of the primary study results.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2024 to primary completion in Jan 2025, 10 months.

Of 203 non-industry interventional studies with no phase under Radiculopathy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 30. This study's 10 months is close to that.

Counting every sponsor, half of 215 studies reached it within 12 months; a quarter within 5 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 24, 2024
First posted
Sep 26, 2024
StartActual
Mar 1, 2024
Primary completionActual
Jan 12, 2025
CompletionActual
Mar 1, 2026
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06615518
Lead sponsor
University of Opole
Responsible party
Kajetan Latka (PhD, Deputy-Head Neurosurgery Department WSS Opole, University of Opole) — Principal investigator
First posted
Sep 26, 2024
Start date
Mar 1, 2024
Primary completion
Jan 12, 2025
Completion
Mar 1, 2026
Last update
Jun 10, 2026

Study contacts

Kajetan Latka, PhD
principal investigator · University of Opole

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion